Johnson & Johnson starts testing covid vaccine in 12 to 17 year olds

posted on 4/2/2021 15:11


Johnson & Johnson (J&J) started testing its covid-19 vaccine on young people aged 12 to 17, in the latest effort to make immunization available to a non-adult audience.

The American company, which is based in New Brunswick (New Jersey) said on Friday that it is expanding a study started in September with adult volunteers to include about 1,700 teenagers aged 12 to 17 years. The test results could be announced in the second half of the year, said a spokesman for J&J.

The pharmaceutical group also plans to start testing the effects of the vaccine on pregnant women.

J&J and Moderna vaccines are authorized for use in adults over 18 years of age in the United States and in some other countries. A third immunizer, from Pfizer with BioNTech, is released for individuals aged 16 and over.


Get the latest news delivered to your inbox

Follow us on social media networks

PREV Government wants to unlock R $ 10 billion in investments in auction week
NEXT Discover the new Nubank that increases the limit with your account balance